Previous Article | Next Article 
Journal of Virology, November 1998, p. 8820-8832, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Rhesus Macaques Infected with Macrophage-Tropic Simian
Immunodeficiency Virus (SIVmacR71/17E) Exhibit
Extensive Focal Segmental and Global Glomerulosclerosis
Edward B.
Stephens,1,*
Chunqiao
Tian,2
Zhuang
Li,1
Opendra
Narayan,1 and
Vincent H.
Gattone II2
Marion Merrell Dow Laboratory of Viral
Pathogenesis, Department of Microbiology, Molecular Genetics and
Immunology,1 and
Department of Anatomy
and Cell Biology,2 University of Kansas Medical
Center, Kansas City, Kansas 66160
Received 28 May 1998/Accepted 7 August 1998
 |
ABSTRACT |
We previously showed that inoculation of rhesus macaques with
molecularly cloned lymphocytetropic simian immunodeficiency virus
(SIVmac239) results in SIV-associated nephropathy (SIVAN) and that the glomerulosclerotic lesions were associated with the selection of macrophagetropic (M-tropic) variants (V. H. Gattone et al., AIDS Res. Hum. Retroviruses 14:1163-1180, 1998). In the present study, seven rhesus macaques were inoculated with M-tropic SIVmacR71/17E, and the renal pathology was examined at
necropsy. All SIVmacR71/17E-infected macaques developed
AIDS, and most developed other systemic complications, including
SIV-induced encephalitis and lentivirus interstitial pneumonia. There
was no correlation between the length of infection (42 to 97 days),
circulating CD4+ T-cell counts, and renal disease. Of the
seven macaques inoculated with SIVmacR71/17E, five
developed significant mesangial hyperplasia and expansion of matrix and
four were clearly azotemic (serum urea nitrogen concentration of 40 to
112 mg/dl). These same five macaques developed focal segmental to
global glomerulosclerotic lesions. Increased numbers of glomerular
CD68+ cells (monocytes/macrophages) were found in glomeruli
but not the tubulointerstitium of the macaques inoculated with
SIVmacR71/17E. All macaques had glomerular deposits of
immunoglobulin G (IgG), IgM, and tubuloreticular inclusions, and six of
seven had IgA deposition. However, there was no correlation between the
presence of circulating anti-SIVmac antibodies,
immunoglobulin deposition, and glomerular disease. Tubulointerstitial
infiltrates were mild, with little or no correlation to azotemia, while
microcystic tubules were evident in those with glomerulosclerosis or
azotemia. The four most severely affected macaques were positive for
diffuse glomerular immunostaining for viral core p27 antigen, and there was intense staining in the glomeruli of the two macaques with the most
severe glomerulosclerosis. Viral sequences were isolated from
glomerular and tubulointerstitial fractions from macaques with severe
glomerulosclerosis but only from the tubulointerstitial compartment of
those that did not develop glomerulosclerosis. Interviral recombinant
viruses generated with env sequences isolated from
glomeruli confirmed the M-tropic nature of the virus found in the
glomeruli. The correlation between the increased number of
CD68+ cells (monocytes/macrophages) in the glomeruli, the
localization of p27 antigen in the glomeruli, and the glomerular
pathology confirms and extends our previous observations of an
association between glomerular infection and infiltration by M-tropic
virus and SIVAN.
 |
INTRODUCTION |
Human immunodeficiency virus type 1 (HIV-1) infection of people results in a gradual loss of
CD4+ T lymphocytes and immunological competence
(52) well as other specific systemic complications that
include encephalopathy (14, 35, 41, 55), interstitial
pneumonia (36, 47, 60), and nephropathies. The most common
nephropathy is known as HIV-associated nephropathy (HIVAN) (3, 4,
6, 9, 20, 43, 44, 53).
Renal failure in HIVAN is associated with enlargement of the kidneys
and is characterized by focal segmental glomerulosclerosis (FSGS) with
proliferation of mesangial cells, increased mesangial matrix, mesangial
hyperplasia, vacuolation of glomerular epithelial cells, and collapse
of the glomerular capillary system (9). Associated with this
glomerular pathology are the deposition of immunoglobulin G (IgG), IgM,
and C3 (9). Histologic changes are observed in the
tubulointerstitium and include dilation of renal tubules, cast
formation, tubular necrosis, and interstitial nephritis (9).
The interstitial nephritis is characterized by fibrosis and
infiltration of mononuclear cells.
Similar to HIV-1 infection of humans, inoculation of simian
immunodeficiency virus (SIV) into rhesus macaques results in AIDS, encephalopathy, and interstitial pneumonia (11, 31, 33, 39).
While the development of neurological disease and interstitial pneumonia in HIV-1-infected patients is associated with the selection of macrophagetropic (M-tropic) variants (5), it is unclear whether development of HIVAN is associated with altered cell tropism of
the virus. In a previous study, we showed that inoculation of rhesus
macaques with the molecularly cloned, lymphocytetropic (L-tropic)
SIVmac239 resulted in renal pathology that was
characterized by focal segmental and global glomerulosclerosis,
increased immunoglobulin and collagen (both type I and type IV)
deposition in the glomerulus, and mild azotemia in some macaques
(16). The glomerular pathology correlated with the
generation of M-tropic variants in these animals (16).
In this study, we have examined whether rhesus macaques inoculated with
pathogenic M-tropic SIVmacR71/17E, recovered from the
brains of macaques with fulminant SIV-induced encephalitis (54,
56), would develop more severe renal disease than macaques inoculated with L-tropic SIVmac239. Our results indicate
that of the seven macaques inoculated with SIVmacR71/17E,
six had significant renal pathology, five developed focal segmental and
global glomerulosclerosis, and four exhibited moderate to severe
azotemia. These results further extend the association of M-tropic
variants of SIVmac with the glomerular pathology and
indicate that SIVmacR71/17E infection of rhesus macaques is
a useful animal model for HIVAN in humans.
(This work was presented at the 30th Annual Meeting of the American
Society of Nephrology, 2 to 5 November 1997, San Antonio, Tex.).
 |
MATERIALS AND METHODS |
Viruses and inoculation of animals.
SIVmacR71/17E was prepared from pooled brain homogenates
prepared from macaques R71 and 17E, both of which developed SIV-induced encephalitis (54). The M-tropic and neurovirulent properties of this virus stock have been previously described (54, 56). L-tropic SIVmac239 was obtained from R. C. Desrosiers,
New England Primate Center, Harvard University. The CEMx174 cell line
(50) was used to prepare stocks of virus as described
previously. CEMx174 cells were maintained in RPMI 1640 supplemented
with 10 mM HEPES buffer (pH 7.3), 2 mM glutamine, 50 µg of gentamicin
per ml, and 10% fetal bovine serum. One milliliter of the
SIVmacR71/17E virus stock, with a titer of approximately
104 50% tissue culture infective doses
(TCID50) per ml, was used to inoculate rhesus macaques
(Macaca mulatta) AQ12, AQ20, AQ38, AQ43, AQ47, AQ69, and
AQ70 via the intravenous route. Macaques W, X, and Y were uninfected
control macaques. The time of euthanasia was dictated by the severity
of their disease to reduce unnecessary pain and suffering.
Virus burdens in macaques at necropsy and CD4 assays.
For
evaluation of the virus burdens at necropsy, heparinized blood was
centrifuged to separate the plasma from the buffy coat. The cells were
centrifuged through Ficoll-Hypaque density gradients to isolate
peripheral blood mononuclear cells (PBMC). The isolated cells were used
in infectious center assays (ICA) to determine the number of PBMC per
106 that were producing infectious, cytopathic virus as
previously described (21). The level of p27 antigen in the
plasma was also evaluated at necropsy by antigen capture assays
(Coulter Corp., Hialeah, Fla.). For enumeration of the CD4+
T cells at necropsy, isolated PBMC were incubated with a monoclonal antibody to CD4 (SIM.4; NIH AIDS Research and Reference Reagent Program). Cells were washed and stained with a fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse IgG (DAKO Corp.,
Carpinteria, Calif.), fixed in 1% buffered formalin, and analyzed on
an EPICS fluorescence-activated cell sorter.
Fractionation of glomerular and tubulointerstitial
fractions.
Freshly harvested kidney tissue was sieved for
isolation of glomeruli and cortical tubules by the method of Savin and
Terreros (51). Cortical tissue was minced into 1- to 3-mm
tissue fragments with scissors and then with a scalpel blade while
being maintained in ice-cold RPMI 1640. Glomeruli were first isolated
by pressing the tissue through a 40-mesh stainless steel screen with
the plunger from a 20-ml syringe. The screen was washed with 50 ml of
RPMI 1640. This material, rich in both tubules and glomeruli, was
sieved through a series of 100-, 150-, and 200-mesh screens, and the retained material was washed with 25 ml of RPMI 1640. In our hands, the
material retained by the 150-mesh screens was rich in glomeruli, while
the material passing through the 200-mesh screen contained mainly
tubules and mononuclear cells. The glomeruli retained by the 150-mesh
sieve were further purified by preparing a series of twofold dilutions
in Dulbecco modified Eagle medium supplemented with 10% fetal bovine
serum. These dilutions were plated into 24-well plates, and those wells
containing only glomeruli and no tubules (determined by microscopy)
were pooled and concentrated by centrifugation. The purity of these
glomerular preparations was greater than 99%. The glomerular and
tubulointerstitial fractions were retained for DNA isolation.
Renal histopathology.
For light microscopy, slices of kidney
tissue were fixed in 10% buffered formalin, embedded in paraffin, and
sectioned (6 µm). Separate sections were stained with hematoxylin and
eosin and periodic acid-Schiff reagent (PAS). Morphological alterations (described below) in the kidneys were semiquantitatively evaluated (scored 0 to 3) from coded slides by two investigators, and the mean
value of the scores was used in statistical analyses. Mesangial cellularity was quantified per mesangial stalk (0 = <3 cells, 1 = 4 to 6 cells, 2 = 7 to 9 cells, 3 = >10 cells),
examining 25 glomeruli per kidney. Mesangial matrix expansion was
defined as a significant increase in matrix (0 = <5% of the
glomeruli involved, 1 = 5 to 25% involved, 2 = 26 to 49%
involved, 3 =
50% involved). Glomerular sclerosis was defined
as glomerular stalks being mainly matrix, with few, if any, open
capillaries; this could be segmental (not all stalks involved) or
global (involving essentially all of the glomerular tuft). The
percentage of sclerotic glomeruli was determined. The percentage of
normal glomeruli (0 for mesangial matrix expansion and 0 for mesangial
cellularity) was also determined. Tubulointerstitial mononuclear
leukocyte infiltration was qualitatively assessed (0 = no
infiltration, 1 = focal infiltration, 2 = multifocal
infiltration, 3 = diffuse infiltration). A Nikon Optiphot
microscope equipped with bright-field and epifluorescence capabilities
was used for all microscopy. Photographs were taken with a Nikon
Microflex HFM photomicroscopy system on Kodak Technical Pan 2415 or
TMAX 400 film. Data were grouped into three categories: SIV-infected
macaques that were PCR positive in the glomerular fraction (group 1;
AQ12, AQ20, AQ47, AQ69, and AQ70), SIV-infected macaques that were
negative for SIV in the glomerular fraction (group 2; AQ38 and AQ43)
and healthy, uninfected macaques (group 3; W, X, and Y). Data were compared by analysis of variance (ANOVA).
For electron microscopy, small segments of cortex were fixed in 2.5%
glutaraldehyde-2% paraformaldehyde in 0.1 M cacodylate buffer. Small
pieces of tissue were rinsed in cacodylate buffer, postfixed in 1%
OsO4, and dehydrated by using a graded series of ethanol.
After being rinsed in propylene oxide, the tissue was embedded in LX112
plastic. Thin sections were cut with a diamond knife and stained with
lead citrate and uranyl acetate prior to being examined with a JEOL
100S transmission electron microscope.
Immunohistochemistry.
Frozen sections of unfixed renal
tissues were cut and fixed in acetone for immunohistochemistry studies.
To identify mononuclear cell types (CD4+ T lymphocytes,
CD8+ T lymphocytes, and CD68+ macrophages),
sections were incubated with mouse monoclonal antibodies directed
against CD4 (SIM.4; NIH AIDS Research and Reference Reagent Program)
and human CD8 and CD68 (DK25 and EMB11, respectively; DAKO). Sections
were incubated with diluted primary antibodies (1:50) overnight at
4°C. A Vectastain Elite ABC kit including a biotinylated goat
anti-mouse antibody and diaminobenzidine with nickel intensification
(Vector Laboratories, Burlingame, Calif.) was used to visualize binding
of the primary antibody. Positive cells were counted by light
microscopy using a 40× objective lens (0.044 mm2 per
field). Ten random fields were evaluated and quantitated to indicate
the average number of positive cells per high-power field from coded
slides. Control sections were incubated with normal mouse sera rather
than primary antibody.
To evaluate kidney tissue for the presence of immunoglobulins, we used
a direct immunofluorescence procedure with FITC-labeled antibodies
(anti-monkey IgG-FITC, anti-monkey IgM-FITC, and anti-monkey IgA-FITC, at dilutions of 1:50; Nordic Immuno Labs, San Clemente, Calif.).
To evaluate extracellular matrix proteins in the kidney, we used
indirect immunofluorescence with primary antibodies against
collagen
type I and collagen type IV (1:100; Chemicon International
Inc.,
Temecula, Calif.). A lissamine rhodamine-labeled secondary
antibody was
visualized in a Nikon Optiphot microscope equipped
with
epifluorescence. Coded sections were qualitatively evaluated
for
glomerular and tubulointerstitial staining as previously described,
using a scoring scale of 1 to 4 as previously described
(
16).
Control sections were incubated with normal rabbit
sera rather
than primary antisera.
To evaluate kidney tissue for the presence of SIV p27 antigen,
acetone-fixed frozen sections were acid treated and stained
by indirect
immunofluorescence methods. The frozen sections were
acetone fixed as
described above and thoroughly dried; then 0.33
M citrate buffer (pH
2.0) was placed on each section for 6 h at
4°C. After being
washed with phosphate-buffered saline, the sections
were subjected to
standard immunohistochemistry methods, including
use of 3% normal goat
serum to block nonspecific IgG binding prior
to the application of the
mouse monoclonal antibody to SIV
macp27
(FA-2; 1:50 in 3%
normal goat serum; NIH AIDS Research and Reference
Reagent Program) for
18 h at 4°C. FITC-labeled rabbit anti-mouse
IgG antibody (1:100;
Organon Teknika Corporation, Cappel Research
Products, Durham, N.C.)
was used to visualize the primary antibody.
Sections were examined, and
staining was quantified on a scale
of 0 to 3, corresponding to no,
mild, moderate, and intense immunoreactivity,
respectively. Normal
mouse serum was used in place of the primary
antibody as the control
for the specificity of the immunohistochemistry.
Immunoprecipitation studies.
To demonstrate the presence or
absence of antibodies directed against SIVmac proteins,
106 CEMx174 cells were inoculated with 104
TCID50 of SIVmacR71/17E. At 3 days
postinoculation, cells were starved for methionine and cysteine and
then radiolabeled with 1 mCi of [35S]methionine and
cysteine for 18 h. The culture medium was retained, and SIV
proteins were immunoprecipitated by using serum samples (20 µl)
obtained at necropsy and protein A-Sepharose as previously described
(58). In additional experiments, KappaLock covalently bound
to Sepharose 4B (Zymed Laboratories) was used in place of protein
A-Sepharose to bring down immunoprecipitates. The advantage of
KappaLock is that it will react strongly with the kappa light chain
from all subclasses of IgG as well as from IgA and IgM (2). To rule out the possibility that antibodies directed against
SIVmac proteins existed as an immune complex and could not
be detected by conventional immunoprecipitation assays, serum samples
were treated at low pH (0.33 M citrate buffer [pH 2.0]) for 1 h,
neutralized, and used immediately in immunoprecipitation assays.
Immunoprecipitates were recovered by using KappaLock-Sepharose 4B as
described above. All immunoprecipitates were washed three times in
radioimmunoprecipitation assay buffer, and samples were denatured by
boiling in sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) sample reducing buffer (32). Proteins were
separated by SDS-PAGE (10% gel) and visualized by standard
autoradiography techniques. Control antisera included a serum sample
from an uninfected macaque and a serum sample from a
SIVmac239-infected macaque that had generated antibodies
against the virus as previously described (62).
Renal function studies.
Sera were collected at the time of
inoculation and necropsy. Sera were assessed for serum urea nitrogen
concentration (SUN) by using a colorimetric assay (kit 640, Sigma
Chemical Co., St. Louis, Mo.). Urine collected at necropsy (when
available) was assessed for protein by the Bio-Rad protein assay
(Bio-Rad Laboratories, Richmond, Calif.).
PCR amplification of gp120 sequences from renal tissues.
Total cellular genomic DNA was extracted from tubulointerstitial and
glomerular fractions of kidneys as well as from lymph node tissue and
then used as a template in nested PCR (48, 49) to amplify
SIV gp120 sequences. The oligonucleotide primers used in the first
round were 5'-GGCTAAGGCTAATACATCTTCTGCATC-3' and 5'-ACCCAAGAACCCTAGCACAAAGACCCC-3', which are complementary
to bases 6565 to 6591 and 8179 and 8205, respectively, of
SIVmac239 (46). One microgram of genomic DNA was
used in the PCR mixture, which contained 4.0 mM MgCl2, 200 µM each of the four deoxynucleoside triphosphates, 100 pM each
oligonucleotide primer, and 2.5 U of Taq polymerase
(Perkin-Elmer Cetus, Norwalk, Conn.). The template was denatured at
92°C for 3 min, and PCR amplification was performed with an automated
DNA Thermal Cycler (Perkin-Elmer Cetus) for 35 cycles of denaturation
at 92°C for 1 min, annealing at 55°C for 1 min, and primer
extension at 72°C for 3 min. Amplification was completed by
incubation of the PCR mixture for 10 min at 72°C. One microliter from
the 100-µl PCR mixture was used in a nested PCR performed under the
reaction conditions described above. For the second round of
amplification, the nested set of primers consisted of
5'-GTAAGTATGGGATGTCTTGGGAATCAG-3' and
5'-GACCCCTCTTTTATTTCTTGAGGTGCC-3', which are complementary
to bases 6598 to 6624 and 8158 to 8184, respectively, of the
SIVmac239 genome (46). To confirm the
specificity of the PCR products, the DNA in the gel was transferred
onto nitrocellulose by the Southern technique and then hybridized with
a 32P-labeled gp120 probe generated by the random primer
labeling method (15). Blots were washed for 30 min at 65°C
with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-0.5% SDS, 0.2× SSC-0.5% SDS, and finally 0.1× SSC-0.5%
SDS. Blots were then exposed to Kodak X-Omat film and processed by
standard autoradiographic procedures. As an internal control for the
amplification process, DNA samples from all tissues were used in PCR
with oligonucleotides that amplified the
-actin gene as previously
described (21, 38). The
-actin gene was amplified from
DNA samples from all tissues analyzed in this report (data not shown).
Other controls done with each PCR included (i) a reaction control with
no template, (ii) a reaction control with no oligonucleotide primers,
(iii) a reaction control with a known template lacking SIV sequences (normal rhesus macaque kidney DNA), and (iv) a positive DNA control (a
plasmid with the gp120 sequence) whose amplified products have been
molecularly cloned and sequenced.
Construction of chimeric viruses.
To determine if the gp120
sequences isolated from the cortical fractions of kidney from the
macaques with the most severe glomerular disease would confer
macrophage tropism onto L-tropic SIVmac239, we
constructed chimeric viruses in which the majority of the
SIVmac239 gp120 sequence (amino acids 107 to 490) was
replaced with the corresponding region from gp120 sequences from AQ20
and AQ47. DNA sequences corresponding to the gp120 region of Env was amplified as described above and digested with NsiI and
ClaI to release a 1,148-bp fragment encoding the variable
(V1 to V5) regions of gp120. The DNA was gel purified and ligated into
a pBS-derived plasmid containing the entire SIVmac239
genome (Stratagene, La Jolla, Calif.) that was also digested with
NsiI and ClaI to release a 1,148-bp fragment
encoding the V1 to V5 regions of gp120. The plasmid was gel purified
and ligated with the NsiI/ClaI fragment isolated
from the pGEM3Zf(
) vector (Promega, Madison, Wis.) containing the
appropriate V1 to V5 sequences. The resulting ligated DNA was used to
transform Escherichia coli JM109, and the resulting transformants were screened for the presence of an
NsiI/ClaI insert. To ensure that the insert
corresponded to the appropriate sequence and that no premature
termination codons were present in the DNA, the entire gp120 region was
sequenced. Plasmids with the correct NsiI/ClaI
fragments were used to transfect CEMx174 cells. Syncytial cytopathic
effect was observed within 48 h of transfection and increased with
continued incubation of cultures. Stock viruses were prepared at 7 days
posttransfection and titrated in CEMx174 cells.
Assessment of macrophage tropism of chimeric viruses.
The
M-tropic nature of the various viral constructs was assessed by the
criteria established for the L-tropic SIVmac239 and a
M-tropic SIVmacLG1 as reported previously (57).
Monolayers of macrophage cultures in 35-mm-diameter dishes were washed
three times with RPMI 1640, inoculated with 0.1 ml of undiluted virus stocks in 0.5 ml of macrophage differentiation medium (MDM), incubated for 2 h at 37°C, and then supplemented with 2 ml of fresh MDM and reincubated for up to 10 days. Macrophage tropism was assessed by
assaying culture medium at 0, 2, 4, 6, 8, and 10 days for the presence
of p27 core antigen. Controls included SIVmac239 as an L-tropic virus and SIVmacLG1 as an M-tropic virus
(57).
Statistical evaluation of data.
ANOVA (one-way) was used to
determine the statistical significance for data on histopathology
(mesangial hyperplasia and expansion), immunohistochemical staining
(p27), immunoglobulin and matrix staining, the density of cellular
infiltrates, and SUN. Table 3 provides means and standard errors of the
means for groups 1 to 3 for several parameters; Tables 2, 4, 5, and 6
provide the individual data derived from each macaque.
 |
RESULTS |
Virus infection in the macaques and kidney.
The macaques used
in this study, the lengths of time for which they were infected with
SIVmacR71/17E, CD4+ T-cell counts, and virus
burdens in the blood and other histopathological observations made at
necropsy are listed in Table 1. The
length of infection varied between 42 to 97 days, and all macaques were actively producing virus at the time of necropsy. All macaques developed typical SIVmac disease, including lymphoid
depletion of lymph nodes (in six of seven macaques), thymic atrophy
(four of seven macaques), and gastrointestinal disease (seven of seven macaques). In addition, six macaques also developed interstitial pneumonia and/or encephalitis, characteristic of this M-tropic strain of SIVmac. As previously shown (16), the
number of circulating CD4+ T cells in the blood did not
correlate with when the macaques became moribund and developed terminal
SIVmac disease. All seven macaques were actively producing
virus from lymph nodes at the time of euthanasia (Table 1).
The renal cortex was isolated from the seven
SIV
macR71/17E-infected macaques and fractionated into
glomerular and tubulointerstitial
fractions. Total DNA was isolated
from each fraction and analyzed
by PCR using oligonucleotide primers
specific for the SIV
mac env gene (specifically
the gp120 region of
env). As shown in Table
1,
SIV
mac sequences were found in the tubulointerstitial
fractions
isolated from all seven macaques. SIV
mac
env sequences were also
detected in the DNA isolated from
the glomerular fractions obtained
from macaques AQ12, AQ20, AQ47, AQ69,
and AQ70 but not from macaques
AQ38 and AQ43. Since SIV sequences were
isolated from the blood
of all of these animals (data not shown) but
not from the glomeruli
from AQ38 and AQ43, blood contamination is
probably not the source
of this virus in the glomerular fractions in
the other macaques.
Renal pathology.
In addition to typical
SIVmacR71/17E-induced disease previously described, we
report here on renal pathology associated with SIVmacR71/17E-infected macaques. The kidneys of macaques
infected with SIVmacR71/17E exhibited both glomerular and
tubulointerstitial lesions. For quantitative comparisons, macaques with
glomeruli that were positive for SIVmac sequences (group 1;
AQ12, AQ20, AQ47, AQ69, and AQ70) were compared with the other macaques
with glomeruli that were negative for SIVmac sequences
(group 2; AQ38 and AQ43) and healthy, uninfected macaques (group 3; W,
X, and Y).
Glomerular lesions were variable between the macaques. All macaques
except AQ43 (and possibly AQ38) exhibited at least some
mesangial cell
proliferation with increased mesangial matrix (PAS
+
glomerular matrix) compared to uninfected control macaques (Tables
2 and
3).
All five macaques with evidence of glomerular SIV
(group 1) exhibited
FSGS (that involved 6 to 30% of the glomeruli)
and global
glomerulosclerosis (that involved 2 to 40% of the glomeruli)
(Tables
2
and
3; Fig.
1a, b, and d). The macaques
without PCR
evidence of glomerular SIV (group 2) or the uninfected
macaques
(group 3) did not exhibit focal segmental or global
glomerulosclerosis
(Tables
2,
3; Fig.
1e and f). By electron
microscopy, increased
matrix material was present in the glomeruli
(Fig.
2a). Glomerular
and peritubular
capillary endothelial cells from all SIV
macR71/17E-infected
macaques had paracrystaloid tubuloreticular inclusions (Fig.
2b).
These
inclusions were also found in endothelial cells of peritubular
capillaries (not shown). Histopathological examination of sections
did
not reveal intranuclear inclusions generally diagnostic for
reactivated
cytomegalovirus infection.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Summary of data for SIVmacR71/17E-infected
macaques (without and with glomerular SIV) and uninfected macaques
|
|

View larger version (203K):
[in this window]
[in a new window]
|
FIG. 1.
Renal histopathology in macaques infected with
SIVmacR71/17E. (a) Light micrograph of AQ20 (a group 1 macaque) with a focus of inflammatory cell infiltrate (arrowhead),
slightly dilated tubules with cast material (arrows), and glomeruli
(g), many of which are sclerotic (magnification, ×25). (b) A globally
sclerotic glomerulus from AQ20 in which mesangial matrix has completely
replaced the glomerular capillaries (magnification, ×100). (c) A
sclerotic glomerulus from AQ47 with peripheral glomerular capillary
collapse and sclerosis associated with the core of each lobule
(magnification, ×100). (d) A glomerulus from AQ70 (a group 1 macaque)
exhibiting FSGS. The top lobe of the glomerulus has numerous
capillaries, while much of the bottom lobe is composed of mesangial
matrix (magnification, ×100). (e and f) Light micrographs of AQ43 (a
group 2 macaque) with normal-appearing kidney parenchyma and glomeruli
(magnifications, ×25 and ×100).
|
|

View larger version (164K):
[in this window]
[in a new window]

View larger version (193K):
[in this window]
[in a new window]
|
FIG. 2.
Electron microscopy of glomerular pathology in macaques
infected with SIVmacR71/17E. (a) Transmission electron
micrograph of a portion of a glomerulus from AQ20 (a group 1 macaque)
with prominent mesangial cells (M) surrounded by excessive amounts of
extracellular matrix including both fibrillar (large arrows) and
fibrous (small arrows) collagenous material. Within some of the
fibrillar matrix are foci of amorphous material which has an increased
electron density consistent with deposits of immunoglobulin
(arrowheads) (magnification, ×7,600). (b) Transmission electron
micrograph of a glomerular capillary loop from AQ43 (a group 2 macaque)
showing a paracrystalloid tubuloreticular inclusion (curved arrow)
within the glomerular endothelial cells. These inclusions were evident
in all SIV-infected macaques (magnification, ×3,800).
|
|
Tubulointerstitial pathology was confined to minimal mononuclear
leukocyte infiltration and mild tubular microcystic dilation
in the
group 1 macaques (Table
2; Fig.
1a and c). The two macaques
which were
negative for glomerular SIV by PCR (group 2) or were
uninfected had no
evidence of tubulointerstitial pathology (Table
2).
Collagen type I and IV reactivity in SIVmac-infected
macaques.
Because an increased deposition of collagen is seen in
sclerotic glomeruli in HIV-1 transgenic mice (30) and in the
kidneys from macaques inoculated with L-tropic SIVmac239
(16), the kidneys from SIVmacR71/17E-infected
and control macaques were examined by immunohistochemistry for collagen
types I and IV. As shown in Tables 3 and
4 and in Fig.
3, glomerular collagen type I and IV
immunoreactivity was highest in those macaques exhibiting focal
segmental and global glomerulosclerosis (group 1; AQ12, AQ20, AQ47,
AQ69, and AQ70 [Fig. 1a and d]) but was also higher in the macaques
without glomerular SIV (group 2; AQ38 and AQ43 [Fig. 1b and e]) than
in the uninfected macaques (Fig. 1c and f). Similarly,
tubulointerstitium staining of collagen I was highest in the group 1 macaques (Table 4), but staining for collagen I also appeared to be
slightly higher in group 2 macaques than in the uninfected controls.
Tubulointerstitium staining for collagen IV was also higher in group 1 macaques than in the uninfected control macaques (Table 4). These data
indicate that interstitial fibrosis was occurring in the macaques with
SIVAN, in a manner similar to that seen in humans with various
glomerulopathies (59).

View larger version (176K):
[in this window]
[in a new window]
|
FIG. 3.
Increased type IV and I collagen deposition in macaques
infected with SIVmacR71/17E. Acetone-fixed frozen sections
from macaques AQ47 (group 1 macaque with severe glomerulosclerosis),
AQ43 (group 2 macaque with minimal renal pathology), and Y (group 3, uninfected) were stained for collagen type IV (a to c) and type I (d to
f) as described in Materials and Methods. (a) Immunofluorescence
staining for collagen IV of a sclerotic glomerulus from AQ47 showing a
relatively homogeneous, dense staining of collagen IV throughout the
glomerulus; (b) immunofluorescence staining for collagen IV of a
glomerulus from AQ43 showing a foci of dense staining of collagen IV
within the glomerulus; (c) immunofluorescence staining for collagen IV
of a normal glomerulus from uninfected macaque Y showing a relatively
light homogeneous staining for collagen IV; (d) immunofluorescence
staining for collagen I of a sclerotic glomerulus from AQ47 showing a
relatively homogeneous, dense staining of collagen I throughout the
glomerulus; (e) immunofluorescence staining for collagen IV of a
glomerulus from AQ43 showing a foci of dense staining of collagen I
within the glomerulus; (f) immunofluorescence staining for collagen I
of a normal glomerulus from uninfected macaque Y to demonstrate the
distribution of collagens from data in Tables 3 and 4. It can be seen
that there was relatively little glomerular staining of collagen I
compared to that evident in infected macaques. (Magnification of all
panels, ×100.)
|
|
Immunoglobulin deposition in the glomeruli.
Since HIVAN (and
HIV immune complex disease) and SIVAN are associated with glomerular
deposits of immunoglobulins, we examined the kidneys from
SIVmac-infected and control macaques for the presence of
immunoglobulin deposits. As shown in Table
5, IgM immunoreactivity was present in
the glomeruli of all SIVmacR71/17E-infected macaques,
whereas none of the uninfected macaques exhibited glomerular IgM. The
IgM immunoreactivity was localized mainly to the mesangial compartment
as described for HIVAN (Fig. 4a). IgG
immunoreactivity in the infected macaques (Fig. 4b), although slightly
weaker than IgM reactivity, was significantly higher than in the
uninfected controls (Fig. 4d). In addition, six of seven macaques
demonstrated significant glomerular IgA immunoreactivity (Fig. 4c).
Control sections incubated with normal rabbit serum showed no specific immunoreactivity. Interestingly, the macaque that survived the shortest
period of time following inoculation with SIVmacR71/17E (AQ43) had no IgA immunoreactivity and the weakest IgG and IgM immunoreactivity. Unlike previous studies showing polyclonal gammopathy in the sera of SIVmac-infected macaques (16),
the results for the SIVmacR71/17E-infected macaques
indicate decreased serum levels of IgG, elevated levels of IgM, and
normal levels of IgA (data not shown). These results suggest that the
increased IgG and IgA glomerular immunoreactivity was not due to
nonspecific trapping of serum immunoglobulins in the widened mesangial
interstitium. By electron microscopy, discrete deposits of
immunoglobulin were evident predominantly in mesangial regions, with
some deposits in the glomerular capillary wall (Fig. 2a).
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Immunoreactive glomerular immunoglobulins, plasma p27
levels, and glomerular p27 staining in
SIVmacR71/17E-infected and uninfected macaques
|
|

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 4.
Deposition of immunoglobulin in the glomeruli of
macaques infected with SIVmacR71/17E. Acetone-fixed frozen
sections from representative macaques were stained for the presence of
IgG, IgM, or IgA as described in Materials and Methods. (a) Micrograph
showing that IgG is present largely within the mesangial region of this
sclerotic glomerulus from macaque AQ20. (b) Micrograph showing that IgM
is localized largely to the mesangial region of this sclerotic
glomerulus from AQ20. (c) IgA is present within this glomerulus from
AQ20. (d) Micrograph showing that there is no IgG (nor IgM or IgA
[data not shown]) in the glomeruli from uninfected macaque Y. (Magnification of all panels, ×100.)
|
|
SIVmac p27 antigen is detected in glomeruli from some
macaques inoculated with SIVmacR71/17E.
We determined
if the SIVmac core antigen (p27) could be localized to
certain regions of the kidney. By immunohistochemistry, SIVmac p27 antigen was detected in the glomeruli but not
the tubulointerstitium from four of the five macaques which were
positive for glomerular SIV by PCR (Fig.
5a and b). Further, the immunostaining
for p27 was most intense in the glomeruli from macaques AQ20 and AQ47, which exhibited the most severe focal segmental and global
glomerulosclerosis (Tables 2 and 5). Core antigen was not detected in
those macaques whose glomeruli were negative for SIV by PCR (group 2)
or in the uninfected macaques (group 3). The p27 antigen did not
colocalize with cells that were positive for staining with anti-CD68
antibody (Fig. 6b) or with areas staining for IgG (Fig. 5c). Also shown in Table 5 are the levels of p27 antigenemia at necropsy. These results
indicate that the detection of p27 antigen in the glomeruli was not the
result of trapping of plasma p27, since macaques negative for
glomerular p27 staining (AQ12, AQ38, and AQ47) also had extremely high
levels of p27 antigen in the plasma. These results indicate a strong
correlation between the presence of viral sequences in the glomeruli,
the presence of viral p27 antigen, and glomerular pathology. These
results also indicated that a productive viral infection was present in
the glomeruli of at least four of the five macaques in group 1.

View larger version (34K):
[in this window]
[in a new window]

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 5.
Glomerular SIVmacp27 antigen in macaques
infected with SIVmacR71/17E. Acetone-fixed frozen sections
of kidney were prepared and stained for the presence of p27 antigen as
described in Materials and Methods. (a) Low-magnification
immunofluorescence micrograph of AQ47 showing that the glomeruli are
the only structures stained (magnification, ×25). (b) Higher
magnification of the same section showing that p27 staining is
relatively uniform throughout the glomerulus. The oval dark regions
appear to be the nuclei of glomerular cells. This pattern of staining
is in sharp contract to the multifocal nature of the staining for
macrophages (compare to the CD68+ cells in Fig. 6b).
Therefore, the p27 staining appears to be in more cells than can be
explained on the basis of resident glomerular macrophages
(magnification, ×100). (c) The glomerulus shown in panel b was stained
for IgG and shows the diffuse but localized deposits of IgG. Since the
patterns of distribution of p27 and IgG do not appear to parallel each
other, it is unlikely that the p27 staining can be explained solely on
the basis of glomerular deposition of IgG-p27 immune complexes
(magnification, ×100).
|
|
Renal function.
SUNs were elevated in group 1 macaques with
evidence of glomerular SIV by PCR and immunohistochemistry (Table 3).
The average SUN in the group 1 macaques was 63 ± 14.6 mg/dl
(range, 28.8 to 112.4 mg/dl), compared to 24.7 ± 0.8 and
26.8 ± 3.3 mg/dl for the group 2 and group 3 macaques,
respectively. These results indicate that mild to severe azotemia was
present in the macaques in group 1. Further, those macaques exhibiting
the most extensive focal segmental and global glomerulosclerosis, AQ20
and AQ47, had the highest SUNs, 112.4 and 76 mg/dl, respectively. The
macaques with the most severe glomerulosclerosis, AQ20 and AQ47, were
also evaluated for proteinuria. Both AQ20 and AQ47 had proteinuria (2 and 1.5 mg/ml, respectively), while macaque AQ43, which had no
glomerulosclerosis, had undetectable amounts of protein in the urine.
Composition of mononuclear infiltrates in the glomeruli and
interstitium.
Glomerular and interstitial inflammatory cell
infiltrates typically occurs with viral infections of the kidney.
Glomerular and tubulointerstitial infiltrates were quantitated in
SIVmac-infected and noninfected macaques. Very few
CD4+ lymphocytes were evident in glomeruli and interstitium
from infected or noninfected kidney tissue (Table
6) despite the finding that all macaques
except AQ20 had CD4+ T-cell levels above 500 cells/µl at
necropsy (Table 1). There were variable numbers of CD8+
lymphocytes in infected and noninfected kidneys (in glomeruli or
interstitium), and the numbers of cells were not statistically different between the three groups of macaques (Table 6). The numbers
of CD68+ cells (monocytes/macrophages) were statistically
increased in the glomerular compartment of macaques in group 1 compared
to group 2 and 3 macaques (Table 6; Fig.
6). There were increased tubulointerstitial CD68+ cells in the two macaques (AQ20
and AQ47) which had the most severe renal disease.
View this table:
[in this window]
[in a new window]
|
TABLE 6.
Mononuclear cell infiltrates in glomerular and
tubulointerstitial compartments of kidneys in
SIVmacR71/17E-infected and uninfected macaques
|
|

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 6.
Macrophage (CD68+ cells) are present in the
kidney of macaques infected with SIVmacR71/17E.
Acetone-fixed frozen sections from the kidneys of macaques AQ20 (with
severe glomerulosclerosis) and AQ43 (with minimal renal pathology) were
stained for the presence of CD68+ cells as described in
Materials and Methods. (a) Low-magnification micrograph of kidney
tissue from AQ20 stained for CD68+ cells
(monocytes/macrophages) in which a few glomeruli (arrowheads) are
evident. There are a number of CD68+ cells (black foci)
scattered throughout the parenchyma (magnification, ×25). (b) Higher
magnification of a glomerulus from AQ20 showing several
CD68+ cells (magnification, ×100). (c) Low-magnification
micrograph of kidney from AQ43 stained for CD68+ cells
(monocytes/macrophages). A few glomeruli (arrowheads) are evident, as
are a number of CD68+ cells (black foci) scattered
throughout the parenchyma (magnification, ×25). (d) Higher
magnification of a glomerulus from AQ43 with only a few
CD68+ cells (magnification, ×100).
|
|
Immune complexes are not responsible for the observed renal
pathology.
We determined whether
SIVmacR71/17E-infected macaques generated antibodies
during the course of infection. Serum samples obtained at necropsy were
used in immunoprecipitation studies with radiolabeled SIVmacR71/17E (Fig. 7). The
results indicate that of the seven macaques inoculated with
SIVmacR71/17E, only two (macaques AQ69 and AQ70) developed
antibodies against SIVmac proteins. Because protein
A-Sepharose preferentially binds to IgG subclasses 1, 2, and 4 but not
to IgG subclass 3 and only weakly to IgA and IgM, the same experiment
was performed with a KappaLock bound to Sepharose 4B, which binds to
the kappa light chains from IgG, IgA, and IgM. The results obtained
were identical to those seen in with protein A-Sepharose (data not
shown). Because all seven macaques had high levels of plasma p27, we
determined if circulating immune complexes were preventing the
detection of antibodies in our immunoprecipitation assays. Serum
samples were pretreated at low pH to disrupt antigen-antibody
complexes, neutralized, and immediately used in immunoprecipitation
assays. Again, the results were identical to those shown in Fig. 7
(data not shown). Taken together, the results from these three
experiments indicate that five of the seven macaques did not develop
antibodies against SIVmac proteins.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 7.
Immunoprecipitation of SIVmac proteins with
serum samples taken from macaques at necropsy.
SIVmacR71/17E (104 TCID50) was used
to inoculate 2 × 106 CEM174 cells. At 4 days
postinoculation, cells were starved for methionine and cysteine and
then radiolabeled with 1,000 µCi of [35S]methionine and
cysteine for 18 h. The culture supernatant was retained, and SIV
proteins were immunoprecipitated with 10 µl of each serum sample and
protein A-Sepharose as described in the text. Immunoprecipitates were
washed three times in radioimmunoprecipitation assay buffer, samples
were denatured by boiling in SDS-PAGE sample reducing buffer, and
proteins were separated by SDS-PAGE (10% gel). Proteins were
visualized by standard autoradiographic techniques. Lanes: 1, SIV
proteins immunoprecipitated from a macaque infected with
SIVmac239; 2, SIV proteins immunoprecipitated with a serum
from an uninfected macaque; 3, SIV proteins immunoprecipitated with
serum from macaque AQ70; 4, SIV proteins immunoprecipitated with serum
from macaque AQ69; 5, SIV proteins immunoprecipitated with serum from
macaque AQ47; 6, SIV proteins immunoprecipitated with serum from
macaque AQ43; 7, SIV proteins immunoprecipitated with serum from
macaque AQ38; 8, SIV proteins immunoprecipitated with serum from
macaque AQ20; 9, SIV proteins immunoprecipitated with serum from
macaque AQ12.
|
|
Chimeric viruses constructed with the V1 to V5 gp120 sequences
isolated from glomerular fractions of AQ20 and AQ47 are M-tropic.
To confirm the M-tropic phenotype of the viruses in the glomeruli, we
constructed chimeric viruses in which the variable (V1 to V5) region of
SIVmac239 gp120 was replaced with the corresponding regions
from gp120 amplified from the glomerular fractions isolated from
macaques AQ20 and AQ47, the two macaques with the most severe glomerular disease. Five chimeric viruses were prepared from the gp120
region amplified from the glomerular fractions of AQ20 and AQ47; the
results from representative clones from each glomerular fraction are
shown. The chimeric viral genomes SIVmacAQ20GLO and SIVmacAQ47GLO were transfected into cultures of CEMx174
cells to prepare stock viruses. Both chimeric viruses replicated
efficiently in CEMx174 cells and caused syncytial cytopathology in
cultures (Fig. 8A). Viruses were then
used to infect rhesus macrophage cultures, which were assayed for the
presence of p27 at several times after inoculation. The results shown
in Fig. 8B indicate that L-tropic SIVmac239 infected rhesus
macrophage cultures very poorly, whereas cultures infected with
SIVmacLG1 (a molecularly cloned M-tropic virus)
released large amounts of p27 into the culture medium over the 10-day
period. Cultures inoculated with SIVmacAQ20GLO and
SIVmacAQ47GLO exhibited a growth curve similar to that
of M-tropic SIVmacLG1 (Fig. 8B). Similar results were obtained for the other four chimeric viruses prepared from the glomerular fraction from each macaque. These data indicate that the
predominant viral species in the glomerular fractions from AQ20 and
AQ47 had an M-tropic phenotype.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 8.
Interviral recombinants constructed with the gp120
regions isolated from the glomerular fractions of macaques AQ20 and
AQ47 are M-tropic. Interviral recombinants were constructed as
described in Materials and Methods and used to inoculate either CEMx174
or rhesus macaque macrophage cultures. (A) Growth curves of
SIVmac239, SIVmacR71/17E,
SIVmacAQ20GLO, and SIVmacAQ47GLO in CEMx174
cultures. CEMx174 cells (106 cells/culture) were inoculated
with 1,000 TCID50 of each virus (multiplicity of infection
of approximately 0.001) for 24 h, washed three times to remove the
virus inoculum, and maintained in the appropriate medium for the course
of the infection. Culture medium was harvested at the time points
indicated and assayed for the presence of p27 antigen as described in
Materials and Methods. , SIVmac239-inoculated CEMx174
cultures; , SIVmacR71/17E-inoculated CEMx174 cultures;
, SIVmacAQ20GLO-inoculated CEMx174 cultures; ,
SIVmacAQ47GLO-inoculated CEMx174 cultures. (B) Growth
curves of SIVmac239, SIVmacLG1,
SIVmacAQ20GLO, and SIVmacAQ47GLO in macrophage
cultures. Rhesus macrophages in 35-mm-diameter dishes were prepared as
described earlier (58). All cultures were inoculated,
washed, and maintained as described above. Culture medium was harvested
at the time points indicated and assayed for the presence of p27
antigen by using antigen capture assays (Coulter Corp.). ,
SIVmac239-inoculated rhesus macrophage cultures; ,
SIVmacR71/17E-inoculated rhesus macrophage cultures; ,
SIVmacAQ20GLO-inoculated rhesus macrophage cultures; ,
SIVmacAQ47GLO-inoculated rhesus macrophage cultures.
|
|
 |
DISCUSSION |
In this study, we showed that five of seven macaques infected with
M-tropic SIVmacR71/17E rapidly developed glomerulosclerotic lesions similar to those in HIVAN (reviewed by Pardo et al.
[40]). The lesions found in SIVAN were also very
similar to glomerular lesions found in mice expressing an HIV transgene
(12, 28, 29). The glomerular changes seen in both HIVAN and
SIVAN described herein include glomerular capillary collapse, mesangial
cell hyperplasia, focal and global glomerulosclerotic lesions with
increased extracellular matrix and immunoglobulin deposits within the
mesangial (and to a lesser extent capillary) matrix, and endothelial
tubuloreticular inclusions. However, there are some dissimilarities
between the SIVAN induced by SIVmacR71/17E and HIVAN in
humans, including the paucity of SIVmacR71/17E-induced
tubulointerstitial changes (with very few small foci of interstitial
inflammatory cells, sparse evidence of microcystic change, and limited
evidence of interstitial fibrosis). Previously, we described more
prominent tubulointerstitial pathology in the kidneys of macaques
infected with L-tropic SIVmac239 (16).
However, SIVmacR71/17E appeared to cause more
glomerulosclerosis and less tubulointerstitial pathology, suggesting that the tubulointerstitial changes are not critical to the
development of the glomerulopathy and renal failure in SIVAN. These
results also suggest that M-tropic SIVmacR71/17E is a more
glomerulopathic virus whereas L-tropic SIVmac239 induces more tubulointerstitial pathology. The glomerulopathic nature of this
virus correlated with renal function data, which indicated that four of
seven macaques inoculated with SIVmacR71/17E developed moderate to severe azotemia. Furthermore, the two macaques with the
most severe focal segmental and global glomerulosclerosis, AQ20 and
AQ47, developed proteinuria, a further indication of renal dysfunction.
These results contrast with those obtained for macaques inoculated with
SIVmac239, which developed only mild azotemia.
We examined the potential relationship(s) between the presence of viral
p27 and the numbers of CD68+ cells in the glomeruli from
infected macaques. While all SIVmacR71/17E-infected macaques had high levels of plasma p27 antigen, not all were positive for glomerular p27 antigen (Table 5). We also found that those macaques
with glomerulosclerosis also had the highest numbers of
CD68+ cells in the glomerulus (Table 3). We found a
statistically significant relationship (by regression analysis) between
the number of CD68+ cells in the glomerulus and the
relative staining for p27 but not between the localization of p27 and
CD68+ cells (Fig. 5b and 6b). Since immunohistochemistry
revealed viral p27 throughout the glomerulus (Fig. 5b), the focal
nature of the CD68+ cells (Fig. 6b) could not account for
all of the viral p27 antigen. The finding of increased numbers of
CD68+ cells in the glomeruli with sclerosis suggests that
these cells may be responsible for ferrying virus into the glomerulus
and/or for exacerbating the viral infection within the glomerulus.
Similarly a recent study has also implicated macrophage infiltration in the pathogenesis of HIV focal segmental glomerulosclerosis
(1). However, the present study indicates that
CD68+ cells are not the only cell type in the glomerulus
infected with the virus. The likelihood that SIVmacR71/17E
infects other cell types in the glomerulus (renal endothelial,
epithelial, and mesangial cells) is supported by studies showing that
HIV-1 can infect human renal endothelial, epithelial, and mesangial
cells (7, 18, 25, 45) and by our recent observations that
primary cultures of glomerular and tubular epithelial cells from rhesus
macaques can be infected with SIVmac (55a).
We also performed studies examining the potential relationship between
the presence of viral p27, immunoglobulin deposition, and the
histopathologic changes in the glomeruli from
SIVmacR71/17E-infected macaques. Our results indicate that
the patterns of cellular distribution of p27 and IgG were not
identical, suggesting that the presence of viral p27 was not due to the
trapping of circulating immune complexes (Fig. 5). These observations
suggest that the p27 present in the kidney was not the result of
nonspecific deposition of immune complexes from the circulation and
cannot be entirely accounted for by infected macrophages within the
glomerulus. Our results indicated neither a relationship between the
relative amount of p27 and glomerular immunoglobulin
staining nor a relationship between the relative amount of
glomerular immunoglobulin staining and glomerulosclerotic changes
(Table 5). However, we found a statistically significant relationship
(by regression analysis) between the amount of immunoglobulin
deposition in the glomerulus and the degree of mesangial cell
hyperplasia in the SIVmacR71/17E-infected macaques.
Mesangioproliferative glomerulonephritis is known to occur secondary to
anti-glomerular basement membrane disease (Goodpasture syndrome) and
other conditions associated with antibody deposition within the
glomerulus (17). Because mesangial hyperplasia seen in
SIVmacR71/17E-infected macaques was seen only in the
context of glomerulosclerosis, it may represent an intermediate
histopathologic state in the progression toward glomerulosclerotic
lesions, which are the lesions correlated with and responsible for the
development of the renal dysfunction. However, the immunoglobulin
deposition may represent the superimposition of immune complex
glomerulonephritis on the glomerulosclerosis. Support for the
relationship between mesangial hyperplasia and FSGS comes from one
study that examined sequential biopsy samples from a
HIV-1-infected patient and showed a diffuse mesangial
hypercellularity that evolved to FSGS (10).
Polyclonal gammopathy and glomerular deposits of IgM are relatively
common in HIV-infected patients, with and without renal disease
(26, 27). Some studies have suggested that immune complex
glomerulonephritis (HIV immune complex disease) is a common nephropathy
reported for HIV-infected patients (27). In a previous study
of four HIV-1 patients with renal disease, the antigen specificity of
these renal antibodies was identified (27). Kidney-eluted IgA and/or IgG reacted with HIV p24 or gp120 in three patients, while
in one patient no HIV protein-antibody complexes were identified. In
acid-treated biopsy sections, p24 was identified by
immunohistochemistry in the same way that we identified SIV p27 core
antigen in glomeruli from SIVmac-infected macaques (Fig.
5). Similar to what was found for HIV-1-infected patients, we
demonstrated significant deposition of not only IgG and IgM but also
IgA in the glomeruli from macaques infected with
SIVmacR71/17E. This finding raised the question as to
whether the deposition of immunoglobulin in the glomeruli was due to
immune complexes formed between antiviral antibodies and viral antigen
or due to nonspecific deposition. Previous studies have shown that
following inoculation with certain strains of SIVmac,
macaques that develop an acute disease characterized by high virus
burdens as measured by ICA and plasma p27 levels rarely develop
antibodies to the virus (62). Thus, it was of interest to
determine if there was an association between severe glomerular disease
and the presence or absence of antiviral antibodies.
Immunoprecipitation studies performed with serum samples obtained at
necropsy indicated that only two of the seven macaques inoculated with
SIVmacR71/17E had developed antibodies against the virus
(Fig. 7). In addition, pretreatment of serum samples at low pH to
disrupt antibody-antigen complexes prior to immunoprecipitation
analysis did not identify anti-SIV antibodies, indicating that the
inability to detect antibodies was not due to the presence of
circulating antibody-antigen complexes. The lack of antiviral
antibodies in five of seven macaques including AQ20 and AQ47, which had
the most severe focal segmental and global glomerulosclerosis,
indicates that the severe glomerular disease observed in these macaques
was not associated with an immune complex-mediated disease involving
antiviral antibodies. These results confirm our observations that the
immunoglobulin deposition and presence of p27 in the glomerulus were
not due to the trapping of antiviral immune complexes. Additionally,
the detection of significant amounts of immunoglobulin in the glomeruli
from infected macaques suggests that the deposition of immunoglobulin
in the glomeruli was either nonspecific in nature or possibly against
clinical or subclinical opportunistic infectious agents. The antigens
to which these glomerular antibodies are directed have yet to be
determined. The similarity between the glomerular pathologic effects
observed in HIVAN and SIVAN described herein suggests that immune
complexes probably do not play a significant role in the pathogenesis
of HIVAN.
The results presented in this report both confirm and extend our
findings that suggest that pathogenic M-tropic strains of SIVmac reproducibly cause a glomerulosclerosis which is
similar to the HIVAN observed in humans. In support of our studies
presented here, a recent study that used a human kidney organ culture
system showed productive replication by M-tropic HIV-1 (BaL strain) and not L-tropic HIV-1 (IIIB strain) (22). Similarly, the HIV MB strain (which has the characteristics of a M-tropic virus) infected glomerular endothelial and mesangial cells, whereas T-cell-tropic HIV
(IIIB strain) did not infect mesangial cells (18). Numerous studies have mapped macrophage tropism of HIV-1 isolates to amino acid
substitutions within the envelope glycoprotein of the virus (8,
19, 24, 34, 37, 61) and differential coreceptor usage by the
virus (13). Recently, chimeric primate lentiviruses containing the tat, rev, vpu, and
env of HIV-1 (strain HXB2) in a genetic background of
L-tropic SIVmac239 that cause severe CD4+
T-cell loss and AIDS, are M-tropic, and cause encephalopathy in rhesus
macaques have been described (42). It will be of interest to
determine if pathogenic molecular clones derived from these virus
stocks are capable of inducing renal disease. Such molecular clones may
permit the identification of HIV-1 genes and amino acid substitutions
that are important in the genesis of primate lentivirus-associated
nephropathy.
 |
ACKNOWLEDGMENTS |
The work reported here was supported by grants DK-49516, AI38492,
NS-32203, and RR06753 from the National Institutes of Health.
We thank Erin McDonough for help in preparing the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Marion Merrell
Dow Laboratory of Viral Pathogenesis, Department of Microbiology,
Molecular Genetics and Immunology, University of Kansas Medical Center, 5000 Wahl East, 3901 Rainbow Blvd., Kansas City, KS 66160. Phone: (913)
588-5575. Fax: (913) 588-5599. E-mail: estephen{at}kumc.edu.
 |
REFERENCES |
| 1.
|
Bodi, I.,
A. A. Abraham, and P. L. Kimmel.
1994.
Macrophages in human immunodeficiency virus-associated kidney diseases.
Am. J. Kidney Dis.
24:762-767[Medline].
|
| 2.
|
Bottomley, S. P.,
J. A. Beckingham,
J. P. Murphy,
M. Atkinson,
R. J. Hinton, and M. G. Gore.
1995.
Cloning, expression, and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus.
Bioseparation
5:359-367[Medline].
|
| 3.
|
Bourgoignie, J. J.
1990.
Renal complications of human immunodeficiency virus type 1.
Kidney Int.
37:1571-1584[Medline].
|
| 4.
|
Bourgoignie, J. J., and V. Pardo.
1991.
The nephropathology in human immunodeficiency virus (HIV-1) infection.
Kidney Int.
40:19-23.
|
| 5.
|
Cheng-Mayer, C.,
C. Weiss,
D. Seto, and J. A. Levy.
1989.
Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.
Proc. Natl. Acad. Sci. USA
86:8575-8579[Abstract/Free Full Text].
|
| 6.
|
Cohen, A. H., and C. C. Nast.
1988.
HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion.
Mod. Pathol.
1:87-97[Medline].
|
| 7.
|
Cohen, A. H.,
N. C. J. Sun,
P. Shapshak, and D. T. Imagawa.
1989.
Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy.
Mod. Pathol.
2:125-128[Medline].
|
| 8.
|
Cordonnier, A.,
L. Montagnier, and M. Emerman.
1989.
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding.
Nature
340:571-574[Medline].
|
| 9.
|
D'Agati, V., and G. B. Appel.
1997.
HIV infection and the kidney.
J. Am. Soc. Nephrol.
8:138-152[Abstract].
|
| 10.
|
D'Agati, V.,
J. L. Suh,
L. Carbone,
J. T. Cheng, and G. Appel.
1989.
The pathology of HIV nephropathy: a detailed morphologic and comparative study.
Kidney Int.
35:1358-1370[Medline].
|
| 11.
|
Desrosiers, R. C.,
A. Hansen-Moosa,
K. Mori,
D. P. Bouvier,
N. W. King,
M. D. Daniel, and D. J. Ringler.
1991.
Macrophage-tropic variants of SIV are associated with specific AIDS related lesions but are not essential for the development of AIDS.
Am. J. Pathol.
139:29-35[Abstract].
|
| 12.
|
Dickie, P.,
J. Felser,
M. Eckhaus,
J. Bryant,
J. Silver,
N. Marinois, and A. L. Notkins.
1991.
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes.
Virology
185:109-119[Medline].
|
| 13.
|
Doms, R. W., and S. C. Peiper.
1997.
Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry.
Virology
235:179-190[Medline].
|
| 14.
|
Epstein, L. G., and H. E. Gendelman.
1993.
Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.
Ann. Neurol.
33:429-436[Medline].
|
| 15.
|
Feinberg, A. P., and B. Vogelstein.
1983.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Anal. Biochem.
132:6-13[Medline].
|
| 16.
|
Gattone, V. H., II,
C. Tian,
W. Zhuge,
M. Sahni,
O. Narayan, and E. B. Stephens.
1998.
SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239.
AIDS Res. Hum. Retroviruses
14:1163-1180[Medline].
|
| 17.
|
Glassock, R. J.,
A. H. Cohen, and S. G. Alder.
1996.
Primary glomerular diseases, p. 1392-1497.
In
B. M. Brenner (ed.), The kidney. W. B. Saunders, Philadelphia, Pa.
|
| 18.
|
Green, D. F.,
L. Resnick, and J. J. Bourgoignie.
1992.
HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro.
Kidney Int.
41:956-960[Medline].
|
| 19.
|
Hirsch, V. M.,
J. E. Martin,
G. Dapolito,
W. R. Elkins,
W. T. London,
S. Goldstein, and P. R. Johnson.
1994.
Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus.
J. Virol.
68:2649-2661[Abstract/Free Full Text].
|
| 20.
|
Humphreys, M. H.
1995.
Human immunodeficiency virus-associated glomerulosclerosis.
Kidney Int.
48:311-320[Medline].
|
| 21.
|
Joag, S. V.,
E. B. Stephens,
R. J. Adams,
L. Foresman, and O. Narayan.
1994.
Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden.
Virology
200:436-446[Medline].
|
| 22.
|
Kanno, Y.,
P. L. Kimmel,
C. H. Fox,
S. Tanawattanacharoen, and J. B. Kopp.
1997.
HIV-1 infects human kidney in organ culture.
J. Am. Soc. Nephrol.
8:619A.
|
| 23.
|
Kestler, H.,
T. Kodama,
D. Ringler,
M. Marthas,
N. Pedersen,
A. Lackner,
D. Regier,
P. Sehgal,
M. Daniel,
N. King, and R. C. Desrosiers.
1990.
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
Science
248:1109-1112[Abstract/Free Full Text].
|
| 24.
|
Kim, F. M.,
D. L. Kolson,
J. W. Balliet,
A. Srinivasan, and R. G. Collman.
1995.
V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate.
J. Virol.
69:1755-1761[Abstract].
|
| 25.
|
Kimmel, P. L.,
A. Ferreira-Centeno,
T. Farkas-Szallasi,
A. A. Abraham, and C. T. Garrett.
1993.
Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome.
Kidney Int.
43:1347-1352[Medline].
|
| 26.
|
Kimmel, P. L.,
T. M. Phillips,
A. Ferreira-Centeno,
T. Farkas-Szallasi,
A. A. Abraham, and C. T. Garrett.
1992.
Idiotypic IgA nephropathy in patients with human immunodeficiency virus infection.
N. Engl. J. Med.
327:702-706[Medline].
|
| 27.
|
Kimmel, P. L.,
T. M. Phillips,
A. Ferreira-Centeno,
T. Farkas-Szallasi,
A. A. Abraham, and C. T. Garrett.
1993.
HIV-associated immune-mediated renal disease.
Kidney Int.
44:1327-1340[Medline].
|
| 28.
|
Klotman, P. E., and A. L. Notkins.
1996.
Transgenic models of human immunodeficiency virus type 1.
Curr. Top. Microbiol. Immunol.
206:197-222[Medline].
|
| 29.
|
Klotman, P. E.,
J. Rappaport,
P. Ray,
J. B. Kopp,
R. Franks,
L. A. Bruggeman, and A. L. Notkins.
1995.
Transgenic models of HIV-1.
AIDS
9:313-324[Medline].
|
| 30.
|
Kopp, J. B.,
M. E. Klotman,
S. H. Adler,
L. A. Bruggeman,
P. Dickie,
N. J. Marinos,
M. Eckhaus,
J. L. Bryant,
A. L. Notkins, and P. E. Klotman.
1992.
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 gene.
Proc. Natl. Acad. Sci. USA
89:1577-1581[Abstract/Free Full Text].
|
| 31.
|
Lackner, A. A.,
L. J. Lowenstine, and P. A. Marx.
1990.
Retroviral infections of the CNS of nonhuman primates.
Curr. Top. Microbiol. Immunol.
160:77-96[Medline].
|
| 32.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 33.
|
Letvin, N. L., and N. W. King.
1990.
Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.
J. Acquired Immune Defic. Syndr.
3:1023-1040.
|
| 34.
|
Liu, Z.,
C. Wood,
J. A. Levy, and C. Cheng-Mayer.
1990.
The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue.
J. Virol.
64:6148-6153[Abstract/Free Full Text].
|
| 35.
|
McArthur, J. C.
1987.
Neurologic manifestations of AIDS.
Medicine
66:407-437[Medline].
|
| 36.
|
Moran, C. A.,
S. Suster,
Z. Pavlova,
F. G. Mullick, and M. N. Koss.
1994.
The spectrum of pathological changes in the lung in children with the acquired immunodeficiency syndrome.
Hum. Pathol.
25:877-882[Medline].
|
| 37.
|
Mori, K.,
D. J. Ringler,
T. Kodama, and R. C. Desrosiers.
1992.
Complex determinants of macrophage tropism in env of simian immunodeficiency virus.
J. Virol.
66:2067-2075[Abstract/Free Full Text].
|
| 38.
|
Nakijima-Iijima, S.,
H. Hamada,
P. Reddy, and T. Kakunaga.
1985.
Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the intron.
Proc. Natl. Acad. Sci. USA
82:6133-6137[Abstract/Free Full Text].
|
| 39.
|
Narayan, O.,
E. B. Stephens,
S. V. Joag, and Y. Chebloune.
1997.
Animal models of human immunodeficiency virus neurological disease, p. 123-140.
In
J. R. Berger, and R. M. Levy (ed.), AIDS and the nervous system. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 40.
|
Pardo, V.,
C. V. Wetli,
J. Strauss, and J. J. Bourgoignie.
1994.
Renal complications of drug abuse and human immunodeficiency virus, p. 390-418.
In
C. C. Tisher, and B. M. Brenner (ed.), Renal pathology with clinical and functional correlations. Lippincott-Raven, Philadelphia, Pa.
|
| 41.
|
Price, R. W., and B. J. Brew.
1988.
The AIDS dementia complex.
J. Infect. Dis.
158:1079-1083[Medline].
|
| 42.
|
Raghavan, R.,
E. B. Stephens,
S. V. Joag,
I. Adany,
D. M. Pinson,
Z. Li,
L. Foresman,
F. Jia,
M. Sahni,
C. Wang,
K. Leung,
L. Foresman, and O. Narayan.
1997.
Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques.
Brain Pathol.
7:851-861[Medline].
|
| 43.
|
Rao, T. K. S.
1991.
Clinical features of human immunodeficiency virus associated nephropathy.
Kidney Int.
40:13-18[Medline].
|
| 44.
|
Rao, T. K. S.,
E. J. Filippone,
A. D. Nicastri,
S. H. Landesman,
E. Frank,
C. K. Chen, and E. A. Freidman.
1984.
Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.
N. Engl. J. Med.
310:669-673[Abstract].
|
| 45.
|
Ray, P. E.,
X.-H. Liu,
D. Henry,
L. Dye III,
L. Xu,
J. M. Orenstein, and T. Schuztbank.
1998.
Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy.
Kidney Int.
53:1217-1229[Medline].
|
| 46.
|
Regier, D. A., and R. C. Desrosiers.
1990.
The complete sequence of a pathogenic molecular clone of simian immunodeficiency virus.
AIDS Res. Hum. Retroviruses
6:1221-1231[Medline].
|
| 47.
|
Rubenstein, A.,
R. Morecki,
B. Silverman,
M. Onarytan,
B. Z. Krieger,
W. Andiamn,
M. N. Ziprkowski, and H. Goldman.
1986.
Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex.
J. Pediatr.
108:498-503[Medline].
|
| 48.
|
Saiki, R. K.,
D. H. Gelfand,
S. Stoffel,
S. J. Scharf,
R. Higuchi,
G. T. Horn,
K. B. Mullis, and H. A. Erlich.
1988.
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
Science
239:487-491[Abstract/Free Full Text].
|
| 49.
|
Saiki, R. K.,
S. Scharf,
F. Faloona,
K. B. Mullis,
G. T. Horn,
H. A. Erlich, and N. Arnheim.
1985.
Enzymatic amplification of -globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
Science
230:1350-1354[Abstract/Free Full Text].
|
| 50.
|
Salter, R. D.,
D. N. Howell, and P. Cresswell.
1985.
Genes regulating HLA class I antigen expression in the T-B lymphoblast hybrids.
Immunogenetics
21:235-246[Medline].
|
| 51.
|
Savin, V. J., and D. A. Terreros.
1981.
Filtration in single isolated mammalian glomeruli.
Kidney Int.
20:188-197[Medline].
|
| 52.
|
Schnittman, S. M., and A. S. Fauci.
1994.
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Adv. Intern. Med.
39:305-355[Medline].
|
| 53.
|
Seney, F. D.,
D. K. Burns, and F. G. Silva.
1995.
Acquired immunodeficiency syndrome and the kidney.
Am. J. Kidney Dis.
16:1-13.
|
| 54.
|
Sharma, D. P.,
M. C. Zink,
M. Anderson,
R. Adams,
J. E. Clements,
S. V. Joag, and O. Narayan.
1992.
Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytotropic parental virus: pathogenesis of infection in macaques.
J. Virol.
66:3550-3556[Abstract/Free Full Text].
|
| 55.
|
Spencer, D. C., and R. W. Price.
1992.
Human immunodeficiency virus and the central nervous system.
Annu. Rev. Microbiol.
46:655-693[Medline].
|
| 55a.
| Stephens, E. Unpublished observations.
|
| 56.
|
Stephens, E. B.,
M. Sahni,
K. Leung,
R. Raghavan,
S. V. Joag, and O. Narayan.
1998.
Nucleotide substitutions in the long terminal repeat (LTR) are not required for development of neurovirulence by simian immunodeficiency virus strain mac.
J. Gen. Virol.
79:1089-1100[Abstract].
|
| 57.
|
Stephens, E. B.,
Z. Q. Liu,
G. W. Zhu,
I. Adany,
S. V. Joag,
L. Foresman,
N. E. J. Berman, and O. Narayan.
1995.
Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
J. Virol.
213:600-613.
|
| 58.
|
Stephens, E. B.,
H. M. McClure, and O. Narayan.
1995.
The proteins of lymphocyte- and macrophage-tropic strains of simian immunodeficiency virus are processed differently in macrophages.
Virology
206:535-544[Medline].
|
| 59.
|
Striker, G. E.,
L. I. Schianuck,
R. E. Cutler, and E. P. Benditt.
1970.
Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease.
Hum. Pathol.
1:615-630[Medline].
|
| 60.
|
Travis, W. D.,
C. H. Fox,
K. O. Devaney,
L. M. Weiss,
T. J. O'Leary,
F. P. Ognibene,
A. F. Suffredini,
M. J. Rosen,
M. B. Cohen, and J. Shelhamer.
1992.
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus.
Hum. Pathol.
23:529-541[Medline].
|
| 61.
|
Westervelt, P.,
D. B. Trowbridge,
L. G. Epstein,
B. M. Blumberg,
Y. Li,
B. H. Hahn,
G. M. Shaw,
R. W. Price, and L. Ratner.
1992.
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
J. Virol.
66:2577-2582[Abstract/Free Full Text].
|
| 62.
|
Zhu, G. W.,
Z. Q. Liu,
S. V. Joag,
D. M. Pinson,
I. Adany,
O. Narayan,
H. M. McClure, and E. B. Stephens.
1995.
Pathogenesis of lymphocyte-tropic and macrophage-tropic SIVmac infection in the brain.
J. Neurovirol.
1:78-91[Medline].
|
Journal of Virology, November 1998, p. 8820-8832, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rosenstiel, P., Gharavi, A., D'Agati, V., Klotman, P.
(2009). Transgenic and Infectious Animal Models of HIV-Associated Nephropathy. J. Am. Soc. Nephrol.
20: 2296-2304
[Abstract]
[Full Text]
-
Hill, M. S., Ruiz, A., Gomez, L. M., Miller, J.-M., Berman, N. E.J., Stephens, E. B.
(2007). APOBEC3G Expression Is Restricted to Epithelial Cells of the Proximal Convoluted Tubules and Is Not Expressed in the Glomeruli of Macaques. J. Histochem. Cytochem.
55: 63-70
[Abstract]
[Full Text]
-
Ross, M. J., Klotman, P. E.
(2002). Recent Progress in HIV-Associated Nephropathy. J. Am. Soc. Nephrol.
13: 2997-3004
[Full Text]
-
Simard, M.-C., Chrobak, P., Kay, D. G., Hanna, Z., Jothy, S., Jolicoeur, P.
(2002). Expression of Simian Immunodeficiency Virus nef in Immune Cells of Transgenic Mice Leads to a Severe AIDS-Like Disease. J. Virol.
76: 3981-3995
[Abstract]
[Full Text]
-
Bannert, N., Schenten, D., Craig, S., Sodroski, J.
(2000). The Level of CD4 Expression Limits Infection of Primary Rhesus Monkey Macrophages by a T-Tropic Simian Immunodeficiency Virus and Macrophagetropic Human Immunodeficiency Viruses. J. Virol.
74: 10984-10993
[Abstract]
[Full Text]